Handelsbanken Fonder
ALXN

Handelsbanken Fonder’s Alexion Pharmaceuticals ALXN Stock Holding History

Handelsbanken Fonder’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-63,235
Closed -$11.6M – 1705
2021
Q2 		$11.6M Buy
63,235
+11,918
+23% +$2.05M 0.06% 300
2021
Q1 		$7.85M Buy
51,317
+1,153
+2% +$178K 0.04% 339
2020
Q4 		$7.84M Hold
50,164
– – 0.05% 325
2020
Q3 		$5.74M Hold
50,164
– – 0.04% 347
2020
Q2 		$5.63M Sell
50,164
-9,836
-16% -$1.04M 0.05% 315
2020
Q1 		$5.39M Buy
+60,000
New +$5.89M 0.12% 143
2019
Q4 		– Sell
-81,746
Closed -$8.01M – 192
2019
Q3 		$8.01M Sell
81,746
-14,750
-15% -$1.66M 0.16% 133
2019
Q2 		$12.6M Buy
96,496
+20,000
+26% +$2.58M 0.23% 112
2019
Q1 		$10.3M Buy
76,496
+16,000
+26% +$1.99M 0.2% 121
2018
Q4 		$5.89M Sell
60,496
-6,704
-10% -$792K 0.12% 141
2018
Q3 		$9.34M Buy
67,200
+21,000
+45% +$2.63M 0.18% 130
2018
Q2 		$5.74M Sell
46,200
-5,000
-10% -$584K 0.11% 142
2018
Q1 		$5.71M Buy
51,200
+3,500
+7% +$418K 0.11% 144
2017
Q4 		$5.7M Buy
47,700
+300
+0.6% +$36.5K 0.13% 131
2017
Q3 		$6.65M Buy
47,400
+3,000
+7% +$408K 0.15% 121
2017
Q2 		$5.4M Buy
44,400
+4,000
+10% +$466K 0.14% 128
2017
Q1 		$4.9M Buy
40,400
+4,000
+11% +$516K 0.14% 119
2016
Q4 		$4.45M Sell
36,400
-3,000
-8% -$367K 0.14% 113
2016
Q3 		$4.83M Buy
39,400
+10,665
+37% +$1.37M 0.14% 121
2016
Q2 		$3.35M Buy
28,735
+4,000
+16% +$568K 0.14% 107
2016
Q1 		$3.44M Sell
24,735
-54,332
-69% -$7.98M 0.15% 109
2015
Q4 		$15.1M Buy
+79,067
New +$13.8M 0.29% 104

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Handelsbanken Fonder's ALXN Position: Q3 2021 in Review

Handelsbanken Fonder sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 63,235 shares — an estimated $11.6M sold.

Handelsbanken Fonder first reported a position in ALXN in Q4 2015 and held it in 22 quarters. The position peaked at $15.1M in Q4 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Handelsbanken Fonder reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Handelsbanken Fonder sold 63,235 Alexion Pharmaceuticals shares in Q3 2021, an estimated $11.6M.
  • Handelsbanken Fonder first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 22 quarters.
  • Handelsbanken Fonder's Alexion Pharmaceuticals position peaked at $15.1M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.